Clinical Trial Update: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows LumiThera's LIGHTSITE IIIB study for dry age-related macular degeneration is in Phase 2/3 and is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• LIGHTSITE IIIB Photobiomodulation

Snippet

Sponsor: LumiThera, Inc. | Conditions: Dry Age-related Macular Degeneration | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING